Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$11.03 - $17.52 $87,137 - $138,408
-7,900 Reduced 41.36%
11,200 $151,000
Q1 2024

May 13, 2024

BUY
$4.12 - $14.17 $78,692 - $270,647
19,100 New
19,100 $258,000
Q2 2023

Aug 11, 2023

SELL
$7.93 - $13.82 $185,562 - $323,388
-23,400 Reduced 35.62%
42,300 $450,000
Q1 2023

May 12, 2023

SELL
$7.65 - $10.38 $297,585 - $403,782
-38,900 Reduced 37.19%
65,700 $547,000
Q4 2022

Feb 13, 2023

SELL
$7.07 - $15.69 $156,954 - $348,318
-22,200 Reduced 17.51%
104,600 $965,000
Q3 2022

Nov 14, 2022

SELL
$12.56 - $22.53 $340,376 - $610,563
-27,100 Reduced 17.61%
126,800 $1.63 Million
Q2 2022

Aug 12, 2022

BUY
$10.36 - $23.93 $1.47 Million - $3.39 Million
141,800 Added 1171.9%
153,900 $2.03 Million
Q1 2022

May 13, 2022

BUY
$17.19 - $26.1 $207,999 - $315,810
12,100 New
12,100 $255,000
Q4 2021

Feb 11, 2022

SELL
$18.11 - $30.72 $1.5 Million - $2.54 Million
-82,800 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$23.65 - $34.44 $35,475 - $51,660
1,500 Added 1.85%
82,800 $2.11 Million
Q2 2021

Aug 13, 2021

BUY
$30.53 - $41.09 $888,423 - $1.2 Million
29,100 Added 55.75%
81,300 $2.74 Million
Q1 2021

May 13, 2021

BUY
$36.08 - $69.81 $1.88 Million - $3.64 Million
52,200 New
52,200 $2.03 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $537M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.